Pirfenidone-loaded hyaluronic acid methacryloyl hydrogel for preventing epidural adhesions after laminectomy

Drug Deliv Transl Res. 2023 Mar;13(3):770-781. doi: 10.1007/s13346-022-01236-0. Epub 2022 Oct 2.

Abstract

It is inevitable that scar formation occurs between the spinal dura and surrounding tissues after laminectomy. While extensive epidural fibrosis, which results in limited nerve root activity and severe pain, is the main cause of postoperative failed-back surgery syndrome. Novel biomaterial loading effective drugs based on reasonable design are eagerly needed for the safe and effective prevention of epidural adhesions. We filtrated a suitable dose of pirfenidone (PFD) to load hyaluronic acid methacryloyl (HAMA) hydrogel in vitro. And then, we compare PFD-loaded HAMA hydrogel with only using PFD or HAMA hydrogels after laminectomy by in vivo studies in rats. We describe a safe and efficient anti-adhesive PFD-loaded HAMA hydrogel that prevents epidural fibrosis through the stable and sustained release of PFD. It was shown that the PFD-loaded HAMA hydrogel effectively inhibited cell penetration and suppressed collagen I/III expression. Thus, it effectively prevented the formation of adhesions through pharmacological and physical processes. The PFD-loaded HAMA hydrogel can effectively prevent adhesion formation in both pharmacological and physical barrier effects.

Keywords: Epidural adhesions; Hyaluronic acid methacryloyl hydrogel; Laminectomy; Pirfenidone.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Epidural Space / pathology
  • Fibrosis
  • Hyaluronic Acid* / pharmacology
  • Hydrogels*
  • Laminectomy / adverse effects
  • Rats
  • Tissue Adhesions / prevention & control

Substances

  • Hyaluronic Acid
  • Hydrogels
  • pirfenidone